IF by specialty › Endocrinology & Metabolism
Diabetes Therapy — Impact Factor
The 2025 Impact Factor of Diabetes Therapy is 4.2 (Q2 in Endocrinology & Metabolism; fully open access).
- Impact Factor
- 4.2 JCR 2025
- JCR category
- Endocrinology & Metabolism
- Quartile
- Q2 in Endocrinology & Metabolism
- Publisher
- Springer Healthcare
- Open access
- fully open access
- IF source
- link.springer.com
Position within the field
Ranked 23 of the 33 journals in Endocrinology & Metabolism on this site (bottom 50%).
Endocrinology & Metabolism journals with a similar Impact Factor
- Diabetes Research and Clinical Practice IF 4.6
- Journal of the Endocrine Society IF 4.4
- BMJ Open Diabetes Research & Care IF 4.4
- Endocrine Practice IF 4.4
- Journal of Endocrinological Investigation IF 4.0
- Journal of Diabetes Investigation IF 3.6
About this value
The Journal Impact Factor of Diabetes Therapy (JCR 2025, released June 2026) is 4.2. Values are compiled by cross-checking figures published by publishers and societies against public aggregators; this is not a reproduction of Clarivate Journal Citation Reports™. Confirm the current value on the publisher's page or in JCR before deciding where to submit. The quartile (Q1–Q4) is the journal's relative position within its JCR category; Q1 means the top 25%.
Last updated September 2026. Report errors via the contact form. Other journals in the same category: Endocrinology & Metabolism.